SCHEMBL21376568

SCHEMBL21376568

C[C@@H](c1ccccc1)N(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CC(N)=O)Cc1ccccc1)Cc1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)C(=O)CN(C(=O)CN(CCCCN)C(=O)CN(Cc1ccccc1)C(=O)CN(Cc1ccccc1)C(=O)CNCCCCN)[C@@H](C)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MC4R P32245 8/20 0.54
MC3R P41968 7/20 0.54
MC1R Q01726 1/20 0.54
REN P00797 1/20 0.39
F2 P00734 1/20 0.38
MC5R P33032 6/20 0.38
HDAC3 O15379 2/20 0.37
HDAC4 P56524 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC7 Q8WUI4 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC10 Q969S8 2/20 0.37
HDAC11 Q96DB2 2/20 0.37
HDAC8 Q9BY41 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37
HDAC9 Q9UKV0 2/20 0.37
HDAC5 Q9UQL6 2/20 0.37
CREBBP Q92793 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21376308 1.00 MC4R (0.54) MC4RMC3RMC1RRENF2
SCHEMBL21376774 1.00 MC4R (0.54) MC4RMC3RMC1RRENF2
SCHEMBL21376767 1.00 MC4R (0.54) MC4RMC3RMC1RRENF2
SCHEMBL21376481 1.00 MC4R (0.54) MC4RMC3RMC1RRENF2
SCHEMBL21376908 1.00 MC4R (0.54) MC4RMC3RMC1RRENF2
SCHEMBL21376909 1.00 MC4R (0.54) MC4RMC3RMC1RRENF2
SCHEMBL21376771 1.00 MC4R (0.54) MC4RMC3RMC1RRENF2
SCHEMBL21376570 0.98 MC4R (0.56) MC4RMC3RMC1RRENF2
SCHEMBL21376479 0.97 MC4R (0.55) MC4RMC3RMC1RRENF2
SCHEMBL21376766 0.97 MC4R (0.55) MC4RMC3RMC1RRENF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10815275-B2 Antimicrobial peptoids with improved selectivity and use thereof GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2020-10-27 US disclosed
US-20190284238-A1 ANTIMICROBIAL PEPTOIDS WITH IMPROVED SELECTIVITY AND USE THEREOF GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2019-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10815275-B2 Antimicrobial peptoids with improved selectivity and use thereof VIP, NOD2, NGLY1 MC4R 1231/4885MC3R 1916/4885MC1R 2893/4885
US-20190284238-A1 ANTIMICROBIAL PEPTOIDS WITH IMPROVED SELECTIVITY AND USE THEREOF VIP, NOD2, FPR3 MC4R 1357/4885MC3R 1749/4885MC1R 3180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.